Subcutaneous Recombinant Interleukin-2 Plus Chemotherapy with Cisplatin and Dacarbazine in Metastatic Melanoma

By Guida M.   Latorre A.   Mastria A.   De Lena M.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 730-733

Elsevier

Access to resources Recommend Favorite

Phase II Study of a Short Course of Weekly High-dose Cisplatin Combined with Long-term Oral Etoposide in Metastatic Malignant Melanoma

By Planting A.S.T.   van der Burg M.E.L.   Goey S.H.   Schellens J.H.M.   Vecht C.   de Boer-Dennert M.   Stoter G.   Verweij J.  

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 2026-2028

Elsevier

Access to resources Recommend Favorite

Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon- after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen

By Atzpodien J.   Lopez Hanninen E.   Kirchner H.   Franzke A.   Korfer A.   Volkenandt M.   Duensing S.   Schomburg A.   Chaitchik S.   Poliwoda H.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 876-881

Elsevier

Access to resources Recommend Favorite

A Phase II Trial of Recombinant Interferon Alpha-2b and Cisplatin in Metastatic Melanoma

By Baekke Janne   Rytter Carsten   Mouridsen Henning   Madsen Ebbe Lindegård   Møholt Kirsten   Bastholt Lars  

Acta Oncologica, Vol. 39, Iss. 5, 2000-10 ,pp. : 625-628

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan

By Kudawara Ikuo  

Journal of Chemotherapy, Vol. 25, Iss. 1, 2013-02 ,pp. : 41-48

Maney Publishing

Access to resources Recommend Favorite